Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 96, Issue 4, 2005, Pages 538-542

  Gogo Jr , Prospero B ^a   Schneider, David J ^a   Terrien, Edward F ^a   Watkins, Matthew W ^a   Sobel, Burton E ^a   Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; NITRIC ACID DERIVATIVE; TROPONIN I;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 23644457318     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.016     Document Type: Article

References (20)

1. B. Modan, S. Schor, M. Shani Acute myocardial infarction prognostic value of white blood cell count and blood glucose level JAMA 233 1975 266 267
2. M.I. Furman, R.C. Becker, J. Yarzebski, J. Savegeau, J.M. Gore, R.J. Goldberg Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction Am J Cardiol 78 1996 945 948
3. V. Menon, D. Lessard, J. Yarzebski, M.I. Furman, J.M. Gore, R.J. Goldberg Leukocytosis and adverse hospital outcomes after acute myocardial infarction Am J Cardiol 92 2003 368 372
4. H.V. Barron, C.P. Cannon, S.A. Murphy, E. Braunwald, C.M. Gibson Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction a Thrombolysis In Myocardial Infarction 10 substudy Circulation 102 2000 2329 2334
5. H.S. Gurm, D.L. Bhatt, R. Gupta, S.G. Ellis, E.J. Topol, M.S. Lauer Preprocedural white blood cell count and death after percutaneous coronary intervention Am Heart J 146 2003 692 698
6. H.S. Gurm, D.L. Bhatt, A.M. Lincoff, J.E. Tcheng, D.J. Kereiakes, N.S. Kleiman, G. Jia, E.J. Topol Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention insights from the EPIC, EPILOG, and EPISTENT trials Heart 89 2003 1200 1204
7. M.I. Furman, J.M. Gore, F.A. Anderson, A. Budaj, S.G. Goodman, A. Avezum, J. Lopez-Sendon, W. Klein, D. Mukherjee, K.A. Eagle, O.H. Dabbous, R.J. Goldberg Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 147 2004 42 48
8. S. Kojima, T. Sakamoto, M. Ishihara, K. Kimura, S. Miyazaki, C. Tei, H. Hiraoka, M. Sonoda, K. Tsuchihashi, M. Yamagishi The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era Ann Med 36 2004 153 160
9. D.L. Bhatt, D.P. Chew, A.M. Lincoff, M.L. Simoons, R.A. Harrington, S.R. Ommen, G. Jia, E.J. Topol Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes Am J Cardiol 92 2003 136 140
10. A. Aggarwal, D.J. Schneider, B.E. Sobel, H.L. Dauerman Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting Am J Cardiol 92 2003 924 929
11. D.P. Chew, D.L. Bhatt, M.A. Robbins, M.S. Penn, J.P. Schneider, M.S. Lauer, E.J. Topol, S.G. Ellis Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention Circulation 104 2001 992 997
12. E. Lindmark, E. Diderholm, L. Wallentin, A. Siegbahn Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113
13. A. Gaspardone, F. Crea, F. Versaci, F. Tomai, A. Pellegrino, L. Chiariello, P.A. Gioffre Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina Am J Cardiol 82 1998 515 518
14. F. Versaci, A. Gaspardone, F. Tomai, F. Crea, L. Chiariello, P.A. Gioffre Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation Am J Cardiol 85 2000 92 95
15. A. Aggarwal, A. Blum, D.J. Schneider, B.E. Sobel, H.L. Dauerman Soluble CD40 ligand is an early initiator of inflammation after coronary intervention Coron Artery Dis 15 2004 471 475
16. M. Dalby, G. Montalescot, S.C. Bal dit, E. Vicaut, T. Soulat, J.P. Collet, R. Choussat, V. Gallois, G. Drobinski, L. Drouet, D. Thomas Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study J Am Coll Cardiol 43 2004 162 168
17. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, J.R. Gallimore, M.B. Pepys Low grade inflammation and coronary heart disease prospective study and updated meta-analyses BMJ 321 2000 199 204
18. M.S. Sabatine, D.A. Morrow, C.P. Cannon, S.A. Murphy, L.A. Demopoulos, P.M. DiBattiste, C.H. McCabe, E. Braunwald, C.M. Gibson Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis in Myocardial Infarction 18) trial substudy J Am Coll Cardiol 40 2002 1761 1768
19. R.E. Kuntz, C.M. Gibson, M. Nobuyoshi, D.S. Baim Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy J Am Coll Cardiol 21 1993 15 25
20. F. Versaci, A. Gaspardone, F. Tomai, F. Ribichini, P. Russo, I. Proietti, A.S. Ghini, V. Ferrero, L. Chiariello, P.A. Gioffre, F. Romeo, F. Crea Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study) J Am Coll Cardiol 40 2002 1935 1942